Last reviewed · How we verify

NCT03888625

Compare the Healing Process of Idiopathic Macular Hole With Different Surgical Techniques

Status unknown NA Last updated 25 March 2019
What this trial tests

NA trial testing Conventional ILM Peeling in Macular Holes in 60 participants. Status unknown.

Timeline
15 June 2018
Primary endpoint
15 June 2020
30 June 2020

Quick facts

Lead sponsorFederal University of São Paulo
PhaseNA
StatusStatus unknown
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingnone
Primary purposetreatment
Enrollment60
Start date15 June 2018
Primary completion15 June 2020
Estimated completion30 June 2020
Sites1 location across Brazil

Drugs / interventions tested

Conditions studied

Sponsor

Federal University of São Paulo

Who can join

18 and older, any sex, with Macular Holes. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

To compare anatomic and functional results, and to evaluate postoperatively the healing process in 2 different techniques for the closure of the macular holes (MH)

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Macular Holes

Currently open trials in the same condition.

Other Federal University of São Paulo trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03888625.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing